NYSE:STE - Steris Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$111.96 +0.65 (+0.58 %)
(As of 07/22/2018 04:00 PM ET)
Previous Close$111.96
Today's Range$111.00 - $112.08
52-Week Range$81.54 - $112.08
Volume232,650 shs
Average Volume380,862 shs
Market Capitalization$9.47 billion
P/E Ratio26.98
Dividend Yield1.11%
Steris logoSTERIS plc develops, manufactures, and markets infection prevention, contamination control, microbial reduction, and surgical and gastrointestinal support products and services for healthcare, pharmaceutical, scientific, research, industrial, and governmental customers worldwide. The company's Healthcare Products segment offers steam, vaporized hydrogen peroxide, and ethylene oxide sterilizers, as well as liquid chemical sterilant processing systems; automated washer/disinfector systems; general and specialty surgical tables, surgical and examination lights, equipment management systems, operating room storage cabinets, warming cabinets, scrub sinks, and other accessories; and gastrointestinal devices and accessories. It also provides OR integration, OR and sterile processing department, workflow, patient tracking, and instrument management solutions; and cleaning chemistries and sterility assurance products. In addition, this segment offers preventive maintenance and repair, sterilization and surgical management consulting, and remote equipment monitoring services, as well as other support services. The company's Healthcare Specialty Services segment provides solutions, and outsourced and managed services for acute care hospitals and other healthcare settings, including instrument and endoscope repair and maintenance solutions; and custom process improvement consulting services. Its Life Sciences segment offers formulated cleaning chemistries, vaporized hydrogen peroxide generators, high-purity water equipment, steam sterilizers, and washers/disinfectors. The company's Applied Sterilization Technologies segment provides contract sterilization services using gamma, electron beam, and X-ray technologies, as well as ethylene oxide gas; and laboratory testing and validation services. It operates a network of 50 facilities. The company was founded in 1985 and is headquartered in Leicester, the United Kingdom.

Receive STE News and Ratings via Email

Sign-up to receive the latest news and ratings for STE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Surgical appliances & supplies
Sub-IndustryHealth Care Equipment


Debt-to-Equity Ratio0.41
Current Ratio2.48
Quick Ratio1.97


Trailing P/E Ratio26.98
Forward P/E Ratio23.77
P/E GrowthN/A

Sales & Book Value

Annual Sales$2.62 billion
Price / Sales3.62
Cash Flow$6.2934 per share
Price / Cash17.79
Book Value$37.92 per share
Price / Book2.95


EPS (Most Recent Fiscal Year)$4.15
Net Income$290.91 million
Net Margins11.10%
Return on Equity11.55%
Return on Assets6.93%


Outstanding Shares84,620,000
Market Cap$9,473.94

Steris (NYSE:STE) Frequently Asked Questions

What is Steris' stock symbol?

Steris trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

How often does Steris pay dividends? What is the dividend yield for Steris?

Steris announced a quarterly dividend on Friday, May 11th. Stockholders of record on Friday, June 8th will be given a dividend of $0.31 per share on Thursday, June 28th. This represents a $1.24 annualized dividend and a dividend yield of 1.11%. The ex-dividend date is Thursday, June 7th. View Steris' Dividend History.

How were Steris' earnings last quarter?

Steris PLC (NYSE:STE) posted its quarterly earnings results on Wednesday, May, 9th. The medical equipment provider reported $1.24 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $1.22 by $0.02. The medical equipment provider had revenue of $716 million for the quarter, compared to analysts' expectations of $703.37 million. Steris had a return on equity of 11.55% and a net margin of 11.10%. Steris's revenue was up 5.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.11 EPS. View Steris' Earnings History.

When is Steris' next earnings date?

Steris is scheduled to release their next quarterly earnings announcement on Tuesday, August, 14th 2018. View Earnings Estimates for Steris.

What guidance has Steris issued on next quarter's earnings?

Steris issued an update on its FY19 earnings guidance on Wednesday, May, 9th. The company provided EPS guidance of $4.63-$4.75 for the period, compared to the Thomson Reuters consensus estimate of $4.69.

What price target have analysts set for STE?

4 equities research analysts have issued 12-month price targets for Steris' stock. Their predictions range from $16.00 to $103.00. On average, they expect Steris' stock price to reach $80.25 in the next twelve months. This suggests that the stock has a possible downside of 28.3%. View Analyst Ratings for Steris.

What is the consensus analysts' recommendation for Steris?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Steris in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Who are some of Steris' key competitors?

Who are Steris' key executives?

Steris' management team includes the folowing people:
  • Mr. Walter M. Rosebrough Jr., Pres, CEO & Director (Age 64)
  • Mr. Michael J. Tokich, Sr. VP, CFO & Treasurer (Age 49)
  • Mr. John Adam Zangerle, VP, Gen. Counsel & Sec. (Age 51)
  • Mr. Daniel A. Carestio, Sr. VP of Applied Sterilization Technologies and Life Sciences (Age 45)
  • Dr. Adrian Vincent Coward, Sr. VP of Healthcare Specialty Services (Age 48)

Has Steris been receiving favorable news coverage?

Media stories about STE stock have trended somewhat positive on Sunday, Accern Sentiment Analysis reports. The research group identifies positive and negative media coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Steris earned a daily sentiment score of 0.24 on Accern's scale. They also assigned press coverage about the medical equipment provider an impact score of 46.05 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.

Who are Steris' major shareholders?

Steris' stock is owned by many different of institutional and retail investors. Top institutional shareholders include Fisher Asset Management LLC (1.70%), Bank of Montreal Can (0.41%), Channing Capital Management LLC (0.16%), Retirement Systems of Alabama (0.13%), West Coast Financial LLC (0.10%) and Sit Investment Associates Inc. (0.03%). Company insiders that own Steris stock include Adrian Vincent Coward, Cynthia L Feldmann, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Richard Martin Steeves, Sudhir K Pahwa, Walter M Rosebrough Jr and Walter M Rosebrough, Jr. View Institutional Ownership Trends for Steris.

Which institutional investors are selling Steris stock?

STE stock was sold by a variety of institutional investors in the last quarter, including Retirement Systems of Alabama, Channing Capital Management LLC, Fisher Asset Management LLC, Municipal Employees Retirement System of Michigan, Sit Investment Associates Inc., West Coast Financial LLC, Benjamin F. Edwards & Company Inc. and Private Trust Co. NA. Company insiders that have sold Steris company stock in the last year include Cynthia L Feldmann, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Richard Martin Steeves, Sudhir K Pahwa, Walter M Rosebrough Jr and Walter M Rosebrough, Jr. View Insider Buying and Selling for Steris.

Which institutional investors are buying Steris stock?

STE stock was bought by a variety of institutional investors in the last quarter, including Addenda Capital Inc., Bank of Montreal Can, Clinton Group Inc., State of Alaska Department of Revenue, Empirical Finance LLC, Addenda Capital Inc. and Louisiana State Employees Retirement System. View Insider Buying and Selling for Steris.

How do I buy shares of Steris?

Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Steris' stock price today?

One share of STE stock can currently be purchased for approximately $111.96.

How big of a company is Steris?

Steris has a market capitalization of $9.47 billion and generates $2.62 billion in revenue each year. The medical equipment provider earns $290.91 million in net income (profit) each year or $4.15 on an earnings per share basis. Steris employs 12,000 workers across the globe.

How can I contact Steris?

Steris' mailing address is Rutherford House Stephensons Way Chaddesden, Derby X0, DE21 6LY. The medical equipment provider can be reached via phone at 44-13-3238-7100 or via email at [email protected]

MarketBeat Community Rating for Steris (NYSE STE)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  172 (Vote Outperform)
Underperform Votes:  248 (Vote Underperform)
Total Votes:  420
MarketBeat's community ratings are surveys of what our community members think about Steris and other stocks. Vote "Outperform" if you believe STE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe STE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.